| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiography, Interventional | 18 | 2020 | 150 | 3.010 |
Why?
|
| Radiology | 7 | 2020 | 194 | 2.530 |
Why?
|
| Vena Cava Filters | 9 | 2019 | 96 | 1.860 |
Why?
|
| Pulmonary Embolism | 7 | 2020 | 222 | 1.710 |
Why?
|
| Liver Transplantation | 13 | 2015 | 1271 | 1.690 |
Why?
|
| Societies, Medical | 11 | 2020 | 573 | 1.630 |
Why?
|
| Vena Cava, Inferior | 9 | 2016 | 143 | 1.610 |
Why?
|
| Stents | 11 | 2018 | 377 | 1.590 |
Why?
|
| Cholestasis | 3 | 2019 | 47 | 1.440 |
Why?
|
| Diagnostic Imaging | 11 | 2020 | 469 | 1.410 |
Why?
|
| Catheterization, Central Venous | 9 | 2017 | 116 | 1.390 |
Why?
|
| Device Removal | 11 | 2019 | 161 | 1.210 |
Why?
|
| Evidence-Based Medicine | 12 | 2020 | 429 | 1.200 |
Why?
|
| Embolization, Therapeutic | 6 | 2014 | 238 | 1.160 |
Why?
|
| Venous Thrombosis | 5 | 2020 | 243 | 1.160 |
Why?
|
| Drainage | 6 | 2015 | 157 | 1.070 |
Why?
|
| Catheters, Indwelling | 9 | 2013 | 110 | 0.980 |
Why?
|
| Catheterization | 8 | 2009 | 232 | 0.950 |
Why?
|
| Renal Dialysis | 8 | 2009 | 355 | 0.880 |
Why?
|
| United States | 17 | 2020 | 6681 | 0.860 |
Why?
|
| Median Arcuate Ligament Syndrome | 3 | 2018 | 23 | 0.830 |
Why?
|
| Postoperative Complications | 5 | 2013 | 2207 | 0.800 |
Why?
|
| Computed Tomography Angiography | 3 | 2020 | 131 | 0.790 |
Why?
|
| Ultrasonography, Doppler, Color | 2 | 2018 | 38 | 0.790 |
Why?
|
| Biliary Tract Diseases | 2 | 2015 | 34 | 0.790 |
Why?
|
| Arterial Occlusive Diseases | 3 | 2017 | 107 | 0.780 |
Why?
|
| Celiac Artery | 2 | 2018 | 25 | 0.760 |
Why?
|
| Decompression, Surgical | 3 | 2018 | 87 | 0.760 |
Why?
|
| Portal Vein | 6 | 2013 | 120 | 0.740 |
Why?
|
| Endovascular Procedures | 2 | 2014 | 218 | 0.720 |
Why?
|
| Urinary Tract | 1 | 2020 | 34 | 0.720 |
Why?
|
| Practice Guidelines as Topic | 5 | 2015 | 1037 | 0.720 |
Why?
|
| Angioplasty | 3 | 2017 | 70 | 0.660 |
Why?
|
| Humans | 74 | 2020 | 86678 | 0.650 |
Why?
|
| Venous Thromboembolism | 2 | 2019 | 153 | 0.650 |
Why?
|
| Femoral Vein | 4 | 2014 | 35 | 0.640 |
Why?
|
| Catheterization, Peripheral | 2 | 2017 | 58 | 0.640 |
Why?
|
| Jugular Veins | 4 | 2014 | 69 | 0.630 |
Why?
|
| Constriction, Pathologic | 10 | 2018 | 213 | 0.620 |
Why?
|
| Iliac Artery | 1 | 2017 | 35 | 0.620 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 4 | 2017 | 40 | 0.620 |
Why?
|
| Mesenteric Ischemia | 1 | 2017 | 4 | 0.610 |
Why?
|
| Treatment Outcome | 23 | 2018 | 7998 | 0.610 |
Why?
|
| Infant Mortality | 2 | 2016 | 59 | 0.610 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2018 | 237 | 0.570 |
Why?
|
| Prosthesis Implantation | 2 | 2016 | 125 | 0.570 |
Why?
|
| Leiomyoma | 2 | 2018 | 191 | 0.560 |
Why?
|
| Uterine Neoplasms | 2 | 2018 | 227 | 0.560 |
Why?
|
| Vena Cava, Superior | 4 | 2014 | 59 | 0.550 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2015 | 62 | 0.530 |
Why?
|
| Hepatic Artery | 2 | 2013 | 83 | 0.520 |
Why?
|
| Endoleak | 2 | 2012 | 35 | 0.520 |
Why?
|
| Abscess | 1 | 2015 | 91 | 0.510 |
Why?
|
| Infant, Premature | 3 | 2016 | 290 | 0.500 |
Why?
|
| Vascular Diseases | 2 | 2014 | 121 | 0.500 |
Why?
|
| Brachiocephalic Veins | 2 | 2014 | 33 | 0.490 |
Why?
|
| Thrombectomy | 2 | 2013 | 158 | 0.480 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2012 | 112 | 0.480 |
Why?
|
| Laparoscopy | 3 | 2018 | 754 | 0.480 |
Why?
|
| Hemoptysis | 2 | 2014 | 24 | 0.480 |
Why?
|
| Congenital Abnormalities | 1 | 2014 | 63 | 0.480 |
Why?
|
| Graft Occlusion, Vascular | 5 | 2007 | 99 | 0.470 |
Why?
|
| Prenatal Diagnosis | 1 | 2014 | 104 | 0.460 |
Why?
|
| Cholangiography | 3 | 2005 | 41 | 0.460 |
Why?
|
| Thrombin | 1 | 2013 | 61 | 0.450 |
Why?
|
| Abdominal Injuries | 1 | 2013 | 39 | 0.450 |
Why?
|
| Mesenteric Veins | 1 | 2013 | 34 | 0.450 |
Why?
|
| Palliative Care | 2 | 2014 | 257 | 0.440 |
Why?
|
| Aneurysm, False | 1 | 2013 | 54 | 0.440 |
Why?
|
| Hypertension, Portal | 2 | 2012 | 47 | 0.440 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2013 | 92 | 0.430 |
Why?
|
| Aneurysm, Ruptured | 1 | 2012 | 51 | 0.420 |
Why?
|
| Female | 43 | 2018 | 44550 | 0.410 |
Why?
|
| Endoscopy | 1 | 2015 | 332 | 0.410 |
Why?
|
| Thrombolytic Therapy | 2 | 2013 | 220 | 0.390 |
Why?
|
| Contrast Media | 5 | 2019 | 1078 | 0.380 |
Why?
|
| Ultrasonography, Interventional | 4 | 2013 | 121 | 0.380 |
Why?
|
| Prosthesis Design | 7 | 2016 | 278 | 0.370 |
Why?
|
| Body Fluids | 1 | 2009 | 36 | 0.360 |
Why?
|
| Retrospective Studies | 19 | 2020 | 8496 | 0.360 |
Why?
|
| Acrylic Resins | 1 | 2009 | 22 | 0.360 |
Why?
|
| Male | 39 | 2018 | 40988 | 0.360 |
Why?
|
| Gelatin | 1 | 2009 | 25 | 0.360 |
Why?
|
| Hepatic Duct, Common | 1 | 2009 | 9 | 0.350 |
Why?
|
| Castleman Disease | 1 | 2009 | 13 | 0.350 |
Why?
|
| Iatrogenic Disease | 2 | 2009 | 69 | 0.350 |
Why?
|
| Biliary Fistula | 1 | 2009 | 11 | 0.350 |
Why?
|
| Communicable Diseases | 1 | 2009 | 63 | 0.340 |
Why?
|
| Infant | 7 | 2016 | 3047 | 0.340 |
Why?
|
| Anastomosis, Surgical | 4 | 2009 | 267 | 0.330 |
Why?
|
| Middle Aged | 28 | 2018 | 25040 | 0.330 |
Why?
|
| Pregnancy Outcome | 2 | 2014 | 247 | 0.320 |
Why?
|
| Adult | 22 | 2018 | 25659 | 0.310 |
Why?
|
| Diagnosis, Differential | 4 | 2019 | 1566 | 0.300 |
Why?
|
| Adolescent | 15 | 2018 | 8984 | 0.300 |
Why?
|
| Hemostatics | 3 | 2013 | 56 | 0.300 |
Why?
|
| Budd-Chiari Syndrome | 1 | 2006 | 9 | 0.290 |
Why?
|
| Abdominal Pain | 3 | 2018 | 137 | 0.290 |
Why?
|
| Aged | 22 | 2016 | 18423 | 0.290 |
Why?
|
| Infant, Newborn | 5 | 2016 | 2379 | 0.290 |
Why?
|
| Arteriovenous Shunt, Surgical | 2 | 2005 | 71 | 0.290 |
Why?
|
| Fractures, Compression | 2 | 2018 | 17 | 0.290 |
Why?
|
| Dilatation | 1 | 2006 | 48 | 0.290 |
Why?
|
| Phlebography | 6 | 2016 | 66 | 0.280 |
Why?
|
| Child, Preschool | 9 | 2015 | 3613 | 0.280 |
Why?
|
| Vascular Patency | 5 | 2013 | 126 | 0.270 |
Why?
|
| Spinal Fractures | 2 | 2018 | 75 | 0.270 |
Why?
|
| Splenorenal Shunt, Surgical | 1 | 2005 | 3 | 0.270 |
Why?
|
| Anticoagulants | 4 | 2017 | 408 | 0.270 |
Why?
|
| Perinatology | 1 | 2004 | 14 | 0.250 |
Why?
|
| Kidney Failure, Chronic | 1 | 2009 | 509 | 0.240 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2017 | 2601 | 0.240 |
Why?
|
| Prosthesis Failure | 3 | 2014 | 111 | 0.240 |
Why?
|
| Follow-Up Studies | 9 | 2014 | 3642 | 0.240 |
Why?
|
| Time Factors | 9 | 2018 | 5214 | 0.230 |
Why?
|
| Gastrointestinal Hemorrhage | 5 | 2012 | 230 | 0.210 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 1673 | 0.210 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2001 | 25 | 0.200 |
Why?
|
| Liver Diseases | 2 | 2009 | 241 | 0.200 |
Why?
|
| Hepatic Veins | 2 | 2002 | 27 | 0.200 |
Why?
|
| Bile | 1 | 2001 | 57 | 0.200 |
Why?
|
| Child | 10 | 2013 | 6928 | 0.190 |
Why?
|
| Radiology, Interventional | 3 | 2013 | 68 | 0.190 |
Why?
|
| Hospital Units | 1 | 2020 | 30 | 0.190 |
Why?
|
| Gestational Age | 1 | 2001 | 311 | 0.190 |
Why?
|
| Radiology Department, Hospital | 1 | 2020 | 27 | 0.190 |
Why?
|
| Peer Review | 1 | 2020 | 24 | 0.180 |
Why?
|
| Appointments and Schedules | 1 | 2020 | 53 | 0.180 |
Why?
|
| Radiology Information Systems | 1 | 2020 | 76 | 0.180 |
Why?
|
| Recovery of Function | 2 | 2018 | 272 | 0.180 |
Why?
|
| Radiography | 4 | 2013 | 813 | 0.180 |
Why?
|
| Prospective Studies | 5 | 2020 | 4214 | 0.170 |
Why?
|
| Survival Rate | 3 | 2014 | 1864 | 0.170 |
Why?
|
| Bile Ducts | 1 | 2018 | 59 | 0.170 |
Why?
|
| Fluoroscopy | 6 | 2020 | 119 | 0.160 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2018 | 64 | 0.160 |
Why?
|
| Regional Blood Flow | 1 | 2018 | 197 | 0.160 |
Why?
|
| Blood Flow Velocity | 1 | 2018 | 197 | 0.160 |
Why?
|
| Chylothorax | 1 | 2017 | 7 | 0.150 |
Why?
|
| Endarterectomy | 1 | 2017 | 20 | 0.150 |
Why?
|
| Analgesics | 1 | 2018 | 119 | 0.150 |
Why?
|
| Iliac Vein | 3 | 2011 | 30 | 0.150 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2018 | 166 | 0.150 |
Why?
|
| Vascular Surgical Procedures | 1 | 2018 | 148 | 0.150 |
Why?
|
| Ultrasonography, Doppler, Pulsed | 1 | 1996 | 5 | 0.140 |
Why?
|
| Vasodilator Agents | 1 | 2017 | 152 | 0.140 |
Why?
|
| Live Birth | 1 | 2016 | 14 | 0.140 |
Why?
|
| Pregnancy | 3 | 2014 | 2894 | 0.140 |
Why?
|
| Aged, 80 and over | 10 | 2014 | 6513 | 0.140 |
Why?
|
| Cause of Death | 2 | 2016 | 277 | 0.140 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 257 | 0.140 |
Why?
|
| Prognosis | 3 | 2017 | 3680 | 0.130 |
Why?
|
| Liver Cirrhosis | 2 | 2009 | 300 | 0.130 |
Why?
|
| Risk Assessment | 3 | 2013 | 2264 | 0.130 |
Why?
|
| Angiography | 2 | 2014 | 208 | 0.130 |
Why?
|
| Mental Disorders | 1 | 2018 | 371 | 0.130 |
Why?
|
| New York | 1 | 2014 | 69 | 0.120 |
Why?
|
| Catheter-Related Infections | 1 | 2014 | 23 | 0.120 |
Why?
|
| Central Venous Catheters | 1 | 2014 | 23 | 0.120 |
Why?
|
| Ligaments | 1 | 2013 | 32 | 0.120 |
Why?
|
| Osteoporotic Fractures | 1 | 2014 | 38 | 0.120 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 1802 | 0.120 |
Why?
|
| Injections, Subcutaneous | 1 | 2013 | 117 | 0.110 |
Why?
|
| Fetus | 1 | 2014 | 226 | 0.110 |
Why?
|
| Young Adult | 4 | 2018 | 5980 | 0.110 |
Why?
|
| Esophageal and Gastric Varices | 3 | 2012 | 33 | 0.110 |
Why?
|
| Urokinase-Type Plasminogen Activator | 2 | 2005 | 47 | 0.110 |
Why?
|
| Patient Care Team | 1 | 2015 | 280 | 0.110 |
Why?
|
| Quality of Life | 2 | 2018 | 1585 | 0.110 |
Why?
|
| Treatment Failure | 1 | 2013 | 286 | 0.110 |
Why?
|
| Bile Duct Neoplasms | 1 | 2013 | 79 | 0.110 |
Why?
|
| Extracellular Space | 1 | 1992 | 90 | 0.100 |
Why?
|
| Thoracic Diseases | 1 | 2012 | 25 | 0.100 |
Why?
|
| Angioplasty, Balloon | 3 | 2002 | 95 | 0.100 |
Why?
|
| Healthcare Disparities | 1 | 2016 | 372 | 0.100 |
Why?
|
| Uterine Artery Embolization | 1 | 2011 | 5 | 0.100 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 1686 | 0.100 |
Why?
|
| Embolic Protection Devices | 1 | 2011 | 9 | 0.100 |
Why?
|
| Potassium | 1 | 1992 | 281 | 0.100 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2011 | 43 | 0.100 |
Why?
|
| Gastrostomy | 2 | 2001 | 69 | 0.090 |
Why?
|
| Bile Ducts, Intrahepatic | 2 | 2001 | 70 | 0.090 |
Why?
|
| Thrombosis | 2 | 2006 | 296 | 0.090 |
Why?
|
| Life Tables | 3 | 2005 | 48 | 0.090 |
Why?
|
| Portal System | 1 | 2009 | 13 | 0.090 |
Why?
|
| Adaptation, Physiological | 1 | 1992 | 306 | 0.090 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2012 | 208 | 0.090 |
Why?
|
| Balloon Occlusion | 1 | 2009 | 27 | 0.090 |
Why?
|
| Medical Oncology | 1 | 2012 | 359 | 0.080 |
Why?
|
| Liver Failure | 1 | 2009 | 79 | 0.080 |
Why?
|
| Bariatric Surgery | 1 | 2011 | 194 | 0.080 |
Why?
|
| Obesity, Morbid | 1 | 2011 | 225 | 0.080 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2005 | 92 | 0.080 |
Why?
|
| Graft Survival | 2 | 2009 | 885 | 0.080 |
Why?
|
| Reoperation | 2 | 2013 | 597 | 0.080 |
Why?
|
| Punctures | 2 | 2005 | 29 | 0.080 |
Why?
|
| Peripheral Vascular Diseases | 2 | 2000 | 62 | 0.080 |
Why?
|
| Equipment Safety | 1 | 2007 | 31 | 0.070 |
Why?
|
| Image Enhancement | 1 | 2010 | 563 | 0.070 |
Why?
|
| Prosthesis-Related Infections | 1 | 2007 | 58 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2012 | 738 | 0.070 |
Why?
|
| Bacteremia | 1 | 2007 | 99 | 0.070 |
Why?
|
| Kidney | 1 | 1992 | 1242 | 0.070 |
Why?
|
| Femur | 1 | 2005 | 116 | 0.060 |
Why?
|
| Feasibility Studies | 2 | 2011 | 751 | 0.060 |
Why?
|
| Sweden | 1 | 2004 | 40 | 0.060 |
Why?
|
| Phlebotomy | 2 | 2001 | 21 | 0.060 |
Why?
|
| Staphylococcal Infections | 1 | 2007 | 255 | 0.060 |
Why?
|
| Needles | 2 | 2001 | 35 | 0.060 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2005 | 162 | 0.060 |
Why?
|
| Disabled Children | 1 | 2004 | 43 | 0.060 |
Why?
|
| Obstetric Labor, Premature | 1 | 2004 | 58 | 0.060 |
Why?
|
| Infant, Premature, Diseases | 1 | 2004 | 78 | 0.060 |
Why?
|
| Health Care Rationing | 1 | 2004 | 83 | 0.060 |
Why?
|
| Sex Distribution | 2 | 2014 | 173 | 0.060 |
Why?
|
| Research Design | 1 | 2007 | 594 | 0.060 |
Why?
|
| Cesarean Section | 1 | 2004 | 137 | 0.060 |
Why?
|
| Delphi Technique | 2 | 2014 | 80 | 0.060 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2002 | 228 | 0.060 |
Why?
|
| Venous Pressure | 1 | 2002 | 11 | 0.050 |
Why?
|
| Obstetrics | 1 | 2004 | 120 | 0.050 |
Why?
|
| Deafness | 1 | 2001 | 47 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 747 | 0.050 |
Why?
|
| Risk Factors | 3 | 2018 | 5420 | 0.050 |
Why?
|
| Blindness | 1 | 2001 | 41 | 0.050 |
Why?
|
| Colonic Diseases | 1 | 2001 | 65 | 0.050 |
Why?
|
| Cerebral Palsy | 1 | 2001 | 90 | 0.050 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 58 | 0.050 |
Why?
|
| Intellectual Disability | 1 | 2001 | 186 | 0.050 |
Why?
|
| Workflow | 1 | 2020 | 77 | 0.050 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 1999 | 17 | 0.050 |
Why?
|
| Workload | 1 | 2020 | 128 | 0.040 |
Why?
|
| Saphenous Vein | 1 | 1999 | 61 | 0.040 |
Why?
|
| Plasminogen Activators | 1 | 1999 | 11 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 2262 | 0.040 |
Why?
|
| Chicago | 2 | 2016 | 1380 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2002 | 711 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2001 | 695 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 1998 | 121 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2018 | 150 | 0.040 |
Why?
|
| Pain Management | 1 | 2018 | 127 | 0.040 |
Why?
|
| Lymphography | 1 | 2017 | 27 | 0.040 |
Why?
|
| Mental Health | 1 | 2018 | 162 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2018 | 321 | 0.040 |
Why?
|
| Chronic Pain | 1 | 2018 | 145 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2017 | 320 | 0.030 |
Why?
|
| Glucose | 1 | 1998 | 638 | 0.030 |
Why?
|
| Comorbidity | 1 | 2018 | 944 | 0.030 |
Why?
|
| Vertebroplasty | 1 | 2014 | 8 | 0.030 |
Why?
|
| Kyphoplasty | 1 | 2014 | 7 | 0.030 |
Why?
|
| Aortography | 1 | 2014 | 63 | 0.030 |
Why?
|
| Enteric Nervous System | 1 | 2013 | 8 | 0.030 |
Why?
|
| Diaphragm | 1 | 2013 | 50 | 0.030 |
Why?
|
| Age Distribution | 1 | 2014 | 204 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2013 | 70 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2013 | 132 | 0.030 |
Why?
|
| Endoscopy, Digestive System | 1 | 2013 | 65 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2014 | 152 | 0.030 |
Why?
|
| Illinois | 1 | 2014 | 462 | 0.030 |
Why?
|
| Sodium Bicarbonate | 1 | 1992 | 10 | 0.030 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 1992 | 25 | 0.030 |
Why?
|
| Bicarbonates | 1 | 1992 | 60 | 0.030 |
Why?
|
| Biological Transport, Active | 1 | 1992 | 102 | 0.030 |
Why?
|
| Solutions | 1 | 1992 | 85 | 0.030 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2012 | 28 | 0.030 |
Why?
|
| Expert Testimony | 1 | 2012 | 46 | 0.030 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1992 | 78 | 0.030 |
Why?
|
| Mediastinal Diseases | 1 | 2012 | 21 | 0.030 |
Why?
|
| Dogs | 1 | 1992 | 686 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2013 | 397 | 0.020 |
Why?
|
| Contraceptives, Oral | 1 | 2011 | 46 | 0.020 |
Why?
|
| Contraindications | 1 | 2011 | 72 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1992 | 493 | 0.020 |
Why?
|
| Ultrasonic Therapy | 1 | 2011 | 32 | 0.020 |
Why?
|
| Sodium | 1 | 1992 | 341 | 0.020 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2012 | 153 | 0.020 |
Why?
|
| Retreatment | 2 | 2002 | 107 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2013 | 455 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2013 | 973 | 0.020 |
Why?
|
| Hysterectomy | 1 | 2011 | 146 | 0.020 |
Why?
|
| Uterus | 1 | 2011 | 215 | 0.020 |
Why?
|
| Incidence | 1 | 2014 | 1578 | 0.020 |
Why?
|
| Catheter Ablation | 1 | 2011 | 233 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2011 | 455 | 0.020 |
Why?
|
| Alloys | 1 | 2007 | 10 | 0.020 |
Why?
|
| Biopsy | 1 | 2012 | 1163 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 1992 | 0.020 |
Why?
|
| Cell Line | 1 | 1992 | 2469 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2011 | 770 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 2706 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 3362 | 0.020 |
Why?
|
| Renal Veins | 1 | 2002 | 28 | 0.010 |
Why?
|
| Cadaver | 1 | 2002 | 185 | 0.010 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2001 | 31 | 0.010 |
Why?
|
| Age Factors | 1 | 2005 | 1852 | 0.010 |
Why?
|
| Neoplasms | 1 | 1995 | 2898 | 0.010 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1999 | 41 | 0.010 |
Why?
|
| Stomach | 1 | 2000 | 108 | 0.010 |
Why?
|
| Thigh | 1 | 1999 | 38 | 0.010 |
Why?
|
| Living Donors | 1 | 2002 | 339 | 0.010 |
Why?
|
| Equipment Design | 1 | 2000 | 407 | 0.010 |
Why?
|
| Polytetrafluoroethylene | 1 | 1999 | 74 | 0.010 |
Why?
|
| Rupture | 1 | 1999 | 63 | 0.010 |
Why?
|
| Equipment Failure | 1 | 1999 | 119 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1999 | 244 | 0.010 |
Why?
|
| Veins | 1 | 1999 | 94 | 0.010 |
Why?
|
| Heparin | 1 | 1999 | 175 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 1998 | 103 | 0.010 |
Why?
|
| Recurrence | 1 | 2000 | 1139 | 0.010 |
Why?
|
| Radiographic Image Enhancement | 1 | 1999 | 463 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2000 | 1019 | 0.010 |
Why?
|
| Subclavian Vein | 1 | 1995 | 13 | 0.010 |
Why?
|
| Remission Induction | 1 | 1995 | 722 | 0.010 |
Why?
|
| Animals | 1 | 1992 | 26590 | 0.010 |
Why?
|
| Brain | 1 | 1998 | 2216 | 0.000 |
Why?
|